Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.
Scientific Reports|November 30, 2017
Potential ash impact from Antarctic volcanoes: Insights from Deception Island's most recent eruptionA Geyer, A Marti, S Giralt, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effectA Shimoni, S Giralt, I Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcomeJ L Lee, T Gooley, W Bensinger, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimensR Champlin, van Besien K, S Giralt, et al.
Bone Marrow Transplantation|February 1, 1995
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2L Shaffer, S Giralt, R Champlin, et al.
Bailliere'S Clinical Haematology|June 1, 1997
Natural history and staging of chronic myelogenous leukaemiaJ Cortes, H M Kantarjian, S Giralt, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effectR Champlin, I Khouri, S Komblau, et al.
Current Opinion in Oncology|November 21, 2000
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationD R Couriel, K Hicks, S Giralt, et al.
Pageof 21